These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32691969)

  • 1. Internally Responsive Nanomaterials for Activatable Multimodal Imaging of Cancer.
    Rosenkrans ZT; Ferreira CA; Ni D; Cai W
    Adv Healthc Mater; 2021 Mar; 10(5):e2000690. PubMed ID: 32691969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in intelligent-responsive nanocarriers for cancer therapy.
    Tian M; Xin X; Wu R; Guan W; Zhou W
    Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Microenvironment-Specific Functional Nanomaterials for Biomedical Applications.
    Zhao L; Liu H; Xing Y; Wang R; Cheng Z; Lv C; Lv Z; Yu F
    J Biomed Nanotechnol; 2020 Sep; 16(9):1325-1358. PubMed ID: 33419489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-in-one nanotheranostic platform based on tumor microenvironment: new strategies in multimodal imaging and therapeutic protocol.
    Li Y; Pan X; Hai P; Zheng Y; Shan Y; Zhang J
    Drug Discov Today; 2024 Jul; 29(7):104029. PubMed ID: 38762088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment.
    Ovais M; Mukherjee S; Pramanik A; Das D; Mukherjee A; Raza A; Chen C
    Adv Mater; 2020 Jun; 32(22):e2000055. PubMed ID: 32227413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-activatable nanomedicines for chemodynamic therapy of cancer.
    Wang W; Jin Y; Xu Z; Liu X; Bajwa SZ; Khan WS; Yu H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1614. PubMed ID: 32011108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
    Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
    Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
    Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
    Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
    Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of Multimodal Neuroimaging Using Nanoprobes.
    Sridhar S; Mishra S; Gulyás M; Padmanabhan P; Gulyás B
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28157157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced architectures in the design of responsive polymers for cancer nanomedicine.
    Wagner AM; Spencer DS; Peppas NA
    J Appl Polym Sci; 2018 Jun; 135(24):. PubMed ID: 30174339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in near infrared light responsive multi-functional nanostructures for phototheranostic applications.
    Thangudu S; Kaur N; Korupalli C; Sharma V; Kalluru P; Vankayala R
    Biomater Sci; 2021 Aug; 9(16):5472-5483. PubMed ID: 34269365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-based nanosystems for cancer diagnosis and therapy: Stimuli-responsive, immune response, and clinical studies.
    Moghaddam FD; Zare EN; Hassanpour M; Bertani FR; Serajian A; Ziaei SF; Paiva-Santos AC; Neisiany RE; Makvandi P; Iravani S; Xu Y
    Carbohydr Polym; 2024 Apr; 330():121839. PubMed ID: 38368115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimuli-responsive polymeric nanoparticles for nanomedicine.
    Crucho CI
    ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging.
    Yang Z; Song J; Tang W; Fan W; Dai Y; Shen Z; Lin L; Cheng S; Liu Y; Niu G; Rong P; Wang W; Chen X
    Theranostics; 2019; 9(2):526-536. PubMed ID: 30809290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment.
    Liu G; Lovell JF; Zhang L; Zhang Y
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-traceable theranostic nanoparticles for targeted cancer treatment.
    Anani T; Rahmati S; Sultana N; David AE
    Theranostics; 2021; 11(2):579-601. PubMed ID: 33391494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions.
    Farzin L; Sheibani S; Moassesi ME; Shamsipur M
    J Biomed Mater Res A; 2019 Jan; 107(1):251-285. PubMed ID: 30358098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light-responsive nanomedicine for biophotonic imaging and targeted therapy.
    Son J; Yi G; Yoo J; Park C; Koo H; Choi HS
    Adv Drug Deliv Rev; 2019 Jan; 138():133-147. PubMed ID: 30321619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.